Heterocyclic PIM-kinase inhibitors

Details for Australian Patent Application No. 2009289317 (hide)

Owner Novartis AG

Inventors Burger, Matthew; Lan, Jiong

Agent Davies Collison Cave

Pub. Number AU-A-2009289317

PCT Pub. Number WO2010/026122

Priority 61/093,664 02.09.08 US

Filing date 31 August 2009

Wipo publication date 11 March 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/026122 Priority application(s): WO2010/026122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289319-Picolinamide derivatives as kinase inhibitors

2009289316-Bicyclic kinase inhibitors